Durvalumab in Advanced Biliary Tract Cancer: Real-World Data From a Large Cohort of Patients Across Multiple International Centers.

Rimini M, Fornaro L, Ikeda M, Abidoye O, Lucchetti J, Antonuzzo L, Kim JW, Nichetti F, Saborowski A, Pressiani T, Vivaldi C, Rapposelli IG, Peeters F, Braconi C, Pinato DJ, Tamburini E, Pircher C, Tamberi S, Castet F, Verrico M, Parisi A, Couto N, Chon HJ, Martirena A, Lamarca A, Landriscina M, Fimkelmeier F, Oneda E, Avallone A, Dell'Aquila E, Perkhofer L, Kim IH, Pinto CMS, Garajova I, Kang B, Corallo S, Fenocchio E, Farinea G, Pastorino A, Diana A, Changhoon Y, Schirripa M, Rodriquenz MG, Scartozzi M, Zumstein L, Ghidini M, Prager GW, Aprile G, Spinelli GP, Yung-Yeh S, Chan S, Warmington E, Lancianese A, Bekaii-Saab T, Lavacchi D, Kang M, Lonardi S, Vogel A, Prete AA, Bozzarelli S, Salani F, Persano M, Masi G, Balsano R, Niger M, Camera S, Passeri L, Ferrara M, Satake T, Rimassa L, Casadei-Gardini A

Open source

DOI: 10.1111/liv.70428
Published: 2025 Dec
Container: Liver international : official journal of the International Association for the Study of the Liver
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1111/liv.70428,
  title = {Durvalumab in Advanced Biliary Tract Cancer: Real-World Data From a Large Cohort of Patients Across Multiple International Centers.},
  author = {Rimini M and Fornaro L and Ikeda M and Abidoye O and Lucchetti J and Antonuzzo L and Kim JW and Nichetti F and Saborowski A and Pressiani T and Vivaldi C and Rapposelli IG and Peeters F and Braconi C and Pinato DJ and Tamburini E and Pircher C and Tamberi S and Castet F and Verrico M and Parisi A and Couto N and Chon HJ and Martirena A and Lamarca A and Landriscina M and Fimkelmeier F and Oneda E and Avallone A and Dell'Aquila E and Perkhofer L and Kim IH and Pinto CMS and Garajova I and Kang B and Corallo S and Fenocchio E and Farinea G and Pastorino A and Diana A and Changhoon Y and Schirripa M and Rodriquenz MG and Scartozzi M and Zumstein L and Ghidini M and Prager GW and Aprile G and Spinelli GP and Yung-Yeh S and Chan S and Warmington E and Lancianese A and Bekaii-Saab T and Lavacchi D and Kang M and Lonardi S and Vogel A and Prete AA and Bozzarelli S and Salani F and Persano M and Masi G and Balsano R and Niger M and Camera S and Passeri L and Ferrara M and Satake T and Rimassa L and Casadei-Gardini A},
  year = {2025},
  journal = {Liver international : official journal of the International Association for the Study of the Liver},
  doi = {10.1111/liv.70428},
  url = {https://doi.org/10.1111/liv.70428}
}

RIS

TY  - JOUR
TI  - Durvalumab in Advanced Biliary Tract Cancer: Real-World Data From a Large Cohort of Patients Across Multiple International Centers.
AU  - Rimini M
AU  - Fornaro L
AU  - Ikeda M
AU  - Abidoye O
AU  - Lucchetti J
AU  - Antonuzzo L
AU  - Kim JW
AU  - Nichetti F
AU  - Saborowski A
AU  - Pressiani T
AU  - Vivaldi C
AU  - Rapposelli IG
AU  - Peeters F
AU  - Braconi C
AU  - Pinato DJ
AU  - Tamburini E
AU  - Pircher C
AU  - Tamberi S
AU  - Castet F
AU  - Verrico M
AU  - Parisi A
AU  - Couto N
AU  - Chon HJ
AU  - Martirena A
AU  - Lamarca A
AU  - Landriscina M
AU  - Fimkelmeier F
AU  - Oneda E
AU  - Avallone A
AU  - Dell'Aquila E
AU  - Perkhofer L
AU  - Kim IH
AU  - Pinto CMS
AU  - Garajova I
AU  - Kang B
AU  - Corallo S
AU  - Fenocchio E
AU  - Farinea G
AU  - Pastorino A
AU  - Diana A
AU  - Changhoon Y
AU  - Schirripa M
AU  - Rodriquenz MG
AU  - Scartozzi M
AU  - Zumstein L
AU  - Ghidini M
AU  - Prager GW
AU  - Aprile G
AU  - Spinelli GP
AU  - Yung-Yeh S
AU  - Chan S
AU  - Warmington E
AU  - Lancianese A
AU  - Bekaii-Saab T
AU  - Lavacchi D
AU  - Kang M
AU  - Lonardi S
AU  - Vogel A
AU  - Prete AA
AU  - Bozzarelli S
AU  - Salani F
AU  - Persano M
AU  - Masi G
AU  - Balsano R
AU  - Niger M
AU  - Camera S
AU  - Passeri L
AU  - Ferrara M
AU  - Satake T
AU  - Rimassa L
AU  - Casadei-Gardini A
PY  - 2025
JO  - Liver international : official journal of the International Association for the Study of the Liver
DO  - 10.1111/liv.70428
UR  - https://doi.org/10.1111/liv.70428
ER  -

APA

M, R., L, F., M, I., O, A., J, L., L, A., JW, K., F, N., A, S., T, P., C, V., IG, R., F, P., C, B., DJ, P., E, T., C, P., S, T., F, C., M, V., A, P., N, C., HJ, C., A, M., A, L., M, L., F, F., E, O., A, A., E, D., L, P., IH, K., CMS, P., I, G., B, K., S, C., E, F., G, F., A, P., A, D., Y, C., M, S., MG, R., M, S., L, Z., M, G., GW, P., G, A., GP, S., S, Y., S, C., E, W., A, L., T, B., D, L., M, K., S, L., A, V., AA, P., S, B., F, S., M, P., G, M., R, B., M, N., S, C., L, P., M, F., T, S., L, R., & A, C. (2025). Durvalumab in Advanced Biliary Tract Cancer: Real-World Data From a Large Cohort of Patients Across Multiple International Centers.. Liver international : official journal of the International Association for the Study of the Liver. https://doi.org/10.1111/liv.70428

Source records

pubmed · retrieved 2026-09-26T08:28:18.091Z